Literature DB >> 7090829

[Pharmacological actions of dehydrocorydaline on cardiovascular system (author's transl)].

X R Jiang, Q X Wu, H L Shi, W P Chen, S Q Chang, S Y Zhao, X Y Tian, L F Zhou, S M Guo, Y J Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7090829

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN： 0513-4870


× No keyword cloud information.
  4 in total

1.  Antiatherosclerotic effect of dehydrocorydaline on ApoE-/- mice: inhibition of macrophage inflammation.

Authors:  Bin Wen; Yuan-Ye Dang; Su-Hua Wu; Yi-Min Huang; Kong-Yang Ma; Yi-Ming Xu; Xi-Long Zheng; Xiao-Yan Dai
Journal:  Acta Pharmacol Sin       Date:  2021-09-22       Impact factor: 7.169

2.  Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines.

Authors:  Zhi-Yu Yin; Lu Li; Shuai-Shuai Chu; Qing Sun; Zheng-Liang Ma; Xiao-Ping Gu
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

3.  Effect of wine and vinegar processing of Rhizoma Corydalis on the tissue distribution of tetrahydropalmatine, protopine and dehydrocorydaline in rats.

Authors:  Zhiying Dou; Kefeng Li; Ping Wang; Liu Cao
Journal:  Molecules       Date:  2012-01-18       Impact factor: 4.411

4.  Identification of Metabolites of the Cardioprotective Alkaloid Dehydrocorydaline in Rat Plasma and Bile by Liquid Chromatography Coupled with Triple Quadrupole Linear Ion Trap Mass Spectrometry.

Authors:  Huanyu Guan; Kaitong Li; Xiaoming Wang; Xiaomei Luo; Meifeng Su; Wenting Tan; Xiaoyan Chang; Yue Shi
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.